Weekly operational update on COVID-19 – 20 July 2021

Milestones :: Perspectives :: Research


Weekly operational update on COVID-19 – 20 July 2021
In this edition of the COVID-19 Weekly Operational Update, highlights of country-level actions and WHO support to countries include:
Strengthening clinical management of COVID-19 in Ghana
Receiving 2 million doses of COVID-19 vaccines in Viet Nam donated by the United States of America through the COVAX Facility
COVID-19 readiness and response at Points of Entry in Armenia
Planning and decentralization in Mumbai, India to fight the second COVID-19 surge
Receiving 500 000 vaccines in Haiti donated by the United States of America through the COVAX Facility
Enhancing resilience among parents and children in the Syrian Arab Republic through the “My Hero is You” mental health campaign
Exploring the use of WHO’s COVID-19 vaccination online learning in countries
Progress on a subset of indicators from the SPRP 2021 Monitoring and Evaluation Framework
Updates on WHO’s financing to support countries in SPRP 2021 implementation and provision of critical supplie

Weekly epidemiological update on COVID-19 – 20 July 2021
The global number of new cases reported last week (12-18 July 2021) was over 3.4 million, a 12% increase as compared to the previous week. Globally, COVID-19 case weekly incidence increased with an average of around 490 000 cases reported each day over the past week as compared to 400 000 cases daily in the previous week. Following a steady decline for over two months, the number of weekly deaths reported was similar to the previous week, with almost 57 000 deaths reported. The cumulative number of cases reported globally is now over 190 million and the number of deaths exceeds 4 million.

In this edition, two special focus updates are provided:
:: The release of a WHO COVID-19 detailed surveillance data dashboard, including a downloadable database feature.
:: A detailed update on the phenotypic characteristics (transmissibility, disease severity, risk of reinfection, and impacts on diagnostics and vaccine performance) of SARS-CoV-2 Variants of Concern (VOCs) Alpha, Beta, Gamma and Delta. It also includes updates on the geographic distribution of VOCs.

[Full scale version at link above]